Akihiro Ohashi

8PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

|May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer.

|May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy.

|Nov 19, 2023
CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade.

Tomoko Yamamori Morita, Jie Yu, Yukie Kashima

|Nov 04, 2023
Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB-MMP21 pathway.

Kazuki Nakai, Hancheng Lin, Shotaro Yamano

|Jul 11, 2021
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer.

Yukie Kashima, Daisuke Shibahara, Ayako Suzuki

Pageof 2

Frequent Collaborators

3 joint publications

Jie Yu

3 joint publications

Ryo Kamata

2 joint publications

Kenichi Iwai

2 joint publications

Tadahiro Nambu